ABDULRAHMAN SAEI: Open Payments
NPI 1932574399 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$216 in 8 payments from 8 companies in 2025. Trend: 2023 $16 · 2024 $0 · 2025 $216
Food & beverage: $216
| Company | Payments | Amount |
|---|---|---|
| Imperative Care, Inc | 1 | $81 |
| Novo Nordisk Inc | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: ZOOM 88-T LARGE DISTAL PLATFORM, Kerendia, The Cologuard Plus Collection Kit, LEQVIO, TRELEGY ELLIPTA, FARXIGA, CAPLYTA.
Industry payments across TX — which companies pay providers there.
